Clover Health Investments, Corp Canaccord Genuity's 46th Annual Growth Conference
Review the key takeaways and the transcript of this earnings call.
- Clover Health is a fast-growing Medicare Advantage company focused on empowering physicians with AI-powered technology to identify and manage chronic diseases earlier.
- The company has grown its membership by about 100% over two years, with New Jersey market share increasing from 20% to 31%, making it the number one non-special needs Medicare Advantage plan in that state.
- Clover retains full risk on its business economics, unlike many peers who delegate risk to providers, and operates a 98% PPO network offering broad access to care.
- Two thirds of Clover's members receive at least one visit from a Clover Assistant powered clinician annually, with enrollment in their in-home care program increasing 84% relative to 2025.
- Clover has sustained adjusted EBITDA profitability while growing membership at a 40% CAGR over the last two years and is guiding to its first full year of GAAP net income profitability in 2026.
STOCKNOW INSIGHTS
Continue with outlook and guidance.
Log in to unlock executive comments and Q&A highlights.
Log in for the full summaryStockNow uses AI to translate and summarize earnings calls. Accuracy and completeness are not guaranteed.
Transcript
Preview the first five paragraphs, organized by speaker.
Go ahead with our next presentation. I'm Richard Close with Canaccord Genuity. Again, appreciate everyone joining us for the presentations and meetings here at the Canaccord Genuity Conference. We're excited to have Clover Health, generally speaking, a fast-growing Medicare Advantage company. From management, we have Clay Thornton, Interim Chief Financial Officer. He's going to go through some slides introducing us to Clover Health, and then we'll do some Q&A. Clay? Thank you. Sounds good.
Thanks, Richard. I'll try to be pretty brief this morning, save as much time as we can for Q&A. I'll start really with what is our vision at Clover? I think it's simple to state. It's incredibly difficult to execute. Ultimately, what we're looking to do at Clover is empower every physician with AI-powered technology to identify, manage, and treat chronic disease earlier. Emphasis on the word earlier, which you'll see that appear as I talk through the model here this morning. When we do that, what happens is earlier diagnosis and treatment, earlier disease management, higher quality clinical care, which ultimately outputs affordable and accessible care for our Medicare Advantage members. There's really five pillars where Clover has made structural decisions to be different in our industry.
Those pillars are how we approach technology, how we approach care strategy, how we go into the home through our employed clinicians with Clover Care services, our approach to risk strategy and delegation with providers, and then ultimately, our network strategy. On the technology side, our technology as an insurer is clinically focused, not administratively focused. We've been very intentional about delivering AI-powered physician enablement at scale through our Clover Assistant platform, and I'll talk about that in a little bit more detail later. From care strategy, we're really focused on being proactive versus reactive. One of the biggest problems in healthcare in our country is that healthcare is reactive. By leveraging our technology to identify chronic disease earlier, that makes us proactive and allows us to act before an acute event occurs.
From our Clover Care services arm, you can't just identify disease early, you must continue to treat that on a longitudinal basis, and we do that in the home at scale. From a risk strategy perspective, we retain full risk on the economics of our business. It's very common in the Medicare Advantage space to delegate risk down to the providers. We don't do that at Clover. We take full risk on our business, which means we also have full upside on the economics we produce. Lastly, on our network strategy, we are 98% PPO. What that means is members have broad access to care. They have low-cost in-network benefits, but they can also go anywhere out of network and receive care.
The industry, in general, is starting to retreat from this PPO model and move back toward HMO because that's an easier lever for them to control cost. On the technology side, ultimately, our technology is powered by data and powered by AI and machine learning models. The Clover Assistant platform sits on top of over 100 unique patient data sources, and we run over 100 AI and machine learning models on top of that data. What happens when you do both of those things is you have millions of individualized personal insights that are deployed at the point of care for our Medicare Advantage members. The other important point there is at the point of care. Our clinicians are using our technology when they're in the room with the patient.
FULL TRANSCRIPT
Continue the full translated transcript in StockNow.
Log in to unlock every statement, the English original, and speaker-by-speaker history.
Log in for the full transcriptCall participants
2 people spoke on this call — only 1 are shown here.
PARTICIPANT LIST
View participant details in StockNow.
Log in to see executives and analysts, their roles, and complete speaking history.
Log in to view all participantsKeep exploring
